ANI Pharmaceuticals (NASDAQ:ANIP) reported Q1 2018 earnings this Morning, coming in at $1.32 per share, beating Wall Street’s estimates of $1.28 per Share. Revenue for the quarter came in at $46.48 million missing the streets estimates of $49.93 million Recent Insider Trading for ANI Pharmaceuticals (NASDAQ:ANIP)
- On 4/18/2018 Tracy Marshbanks, Director, sold 33,200 with an average share price of $62.09 per share and the total transaction amounting to $2,061,388.00.
- On 3/19/2018 Daniel Raynor, Director, sold 7,215 with an average share price of $60.85 per share and the total transaction amounting to $439,032.75.
- On 3/14/2018 Arthur Przybyl, Insider, sold 40,000 with an average share price of $61.83 per share and the total transaction amounting to $2,473,200.00.
- On 3/14/2018 Daniel Raynor, Director, sold 27,964 with an average share price of $62.24 per share and the total transaction amounting to $1,740,479.36.
- On 3/12/2018 Tracy Marshbanks, Director, sold 64,221 with an average share price of $63.03 per share and the total transaction amounting to $4,047,849.63.
- On 3/8/2018 Tracy Marshbanks, Director, sold 15,391 with an average share price of $63.08 per share and the total transaction amounting to $970,864.28.
Dividend History for ANI Pharmaceuticals (NASDAQ:ANIP)
Recent Trading for ANI Pharmaceuticals (NASDAQ:ANIP) Shares of ANI Pharmaceuticals closed the previous trading session at 59.66 up +0.27 0.45% with shares trading hands.